Saturday, September 30, 2023
booked.net
Eco-conscious : Print an issue, plant a tree! 

No products in the cart.

  • About
    • Contributors
    • Disclaimers
    • Terms & Conditions
    • Giving back
    • Mission Statement
    • Past Issues
    • Where to Find
    • Call us at 613-935-3763
The Seeker - Positively Local, Suporting Local
  • Home
  • News
  • Opinions
  • Lifestyle
  • Events
  • Columnists
  • Videos
  • Advertise!
    • Online
    • In Print
    • Classifieds
No Result
View All Result
No Result
View All Result

COVID-19 convalescent plasma for patients

The Seeker by The Seeker
April 2, 2020
in News
Reading Time: 2 mins read
13
SHARES

Canadian Blood Services to participate in national clinical trial

OTTAWA, April 02, 2020 (GLOBE NEWSWIRE) — Canadian Blood Services is actively working with Health Canada and the international research community to contribute to the global effort to determine if COVID-19 convalescent plasma could be an effective treatment for the coronavirus.

Canadian Blood Services is part of a team of experts representing Canada on an international working group in partnership with Australia, China, France, Germany, Italy, Singapore, South Korea, the Netherlands, the United Kingdom and the United States.

You might also like

Five Questions with Sip & Scoop owner Jehan Shorish

LTE – Comments on the Bob Turner survey

Ontario’s Minimum Wage to Ascend to $16.55

In Canada, the research community has rallied together to design a national clinical trial on the use of convalescent plasma in treating the virus. An application will be submitted to Health Canada shortly. Pending approval, Canadian Blood Services and Héma-Québec will be responsible for supplying convalescent plasma to hospitals across the country.

“We have the expertise and the infrastructure necessary to collect and prepare convalescent plasma for use in a clinical trial to test its safety and effectiveness as a treatment option,” said Dr. Dana Devine, chief scientist for Canadian Blood Services. “Plasma will only be collected from volunteer donors who have fully recovered from the virus and will be used by Canadian physicians caring for patients with COVID-19 in the context of the clinical trial.”

Once the trial is underway, Canadian Blood Services will contact potential convalescent plasma donors based on defined criteria which will be approved as part of the clinical trial protocol. Convalescent plasma donors will also need to meet current Canadian Blood Services’ donor eligibility criteria. Presently, there is a small, but growing, number of people across Canada who could be eligible to participate as convalescent plasma donors in this trial.

Convalescent plasma is collected through the plasma donation process. When someone contracts a virus, their body develops antibodies against it. The antibodies remain present in their plasma to shield them from possible future infection. In theory, these antibodies could be the key ingredient for a treatment to help others with the same virus.

For more information, watch this video interview with Dr. Devine.

A national clinical trial of this size and scope will require several months to complete. In the meantime, Canadians are urged to donate blood in the next few weeks to help maintain an adequate supply of blood and blood products for patients. The need for blood is constant. Patients undergoing surgery and cancer treatment, injury victims and people living with blood disorders rely on blood products every day. To book an appointment visit blood.ca, download the GiveBlood app or call 1-888-2-DONATE (1-866-236-6283).

Author

  • The Seeker
    The Seeker

    View all posts

Next Post

Incorporate These Ideas For A Grand Wedding Celebration

Inner Site Sidebar

Advertise Here
Facebook Twitter Instagram Youtube TikTok
Don't miss anything!

Get notified of all our new news by ringing the bell at the bottom left corner!

Content Safety

HERO

theseeker.ca

Trustworthy

Approved by Sur.ly

2022
The Seeker Newspaper is located at 327 Second Street E., Cornwall, ON K6H 1Y8 -- All rights reserved
The Seeker does not accept responsibility for errors, misprints or inaccuracies published within. The opinions and statements of our columnists are not to be presumed as the statements and opinions of The Seeker, and should not substitute professional or medical advice.
ISSN 2562-1750 (Print)

ISSN 2562-1769 (Online)
No Result
View All Result
  • Home
  • News
  • Opinions
  • Lifestyle
  • Events
  • Columnists
  • Videos
  • Advertise!
    • Online
    • In Print
    • Classifieds

© 2023 Reducing our footprint!   For every issue we print, we plant a tree!

Select your currency
USD United States (US) dollar
CAD Canadian dollar
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.